In Vitro Susceptibilities of Invasive Isolates of Candida Species: Rapid Increase in Rates of Fluconazole Susceptible-Dose Dependent Candida glabrata Isolates

In Vitro Susceptibilities of Invasive Isolates of Candida Species: Rapid Increase in Rates of Fluconazole Susceptible-Dose Dependent Candida glabrata Isolates Posaconazole against Candida glabrata Isolates with Various Susceptibilities to Fluconazole Assessment of the In Vitro Kinetic Activity of Caspofungin against Candida glabrata In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents Comparative In Vitro Activities of Caspofungin and Micafungin, Determined Using the Method of the European Committee on Antimicrobial Susceptibility Testing, against Yeast Isolates Obtained in France in 2005-2006 Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection Paradoxical Effect of Echinocandins across Candida Species In Vitro: Evidence for Echinocandin-Specific and Candida Species-Related Differences In Vitro Activities of Eight Antifungal Drugs against 55 Clinical Isolates of Fonsecaea spp Posaconazole Activity against Candida glabrata after Exposure to Caspofungin or Amphotericin B Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans